H-CYTE: H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 DaysWound Healing and Limb Salvaging Technology Adds to Company's Asset Portfolio Focused on Unmet Medical Needs

H-CYTE, Inc. announced today that the Company has entered into a letter of intent to acquire SkinDisc, a patent pending tissue regeneration technology, that is expected to close within the next 30 days.